These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

583 related articles for article (PubMed ID: 16567956)

  • 1. Recent advances in globin gene transfer for the treatment of beta-thalassemia and sickle cell anemia.
    Sadelain M
    Curr Opin Hematol; 2006 May; 13(3):142-8. PubMed ID: 16567956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease.
    Sadelain M; Rivella S; Lisowski L; Samakoglu S; Rivière I
    Best Pract Res Clin Haematol; 2004 Sep; 17(3):517-34. PubMed ID: 15498721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress toward the genetic treatment of the beta-thalassemias.
    Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
    Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of globin gene therapy for the treatment of beta-thalassaemia.
    Lisowski L; Sadelain M
    Br J Haematol; 2008 May; 141(3):335-45. PubMed ID: 18410569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell engineering for the treatment of severe hemoglobinopathies.
    Sadelain M; Boulad F; Lisowki L; Moi P; Riviere I
    Curr Mol Med; 2008 Nov; 8(7):690-7. PubMed ID: 18991654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-associated virus 2-mediated transduction and erythroid lineage-restricted long-term expression of the human beta-globin gene in hematopoietic cells from homozygous beta-thalassemic mice.
    Tan M; Qing K; Zhou S; Yoder MC; Srivastava A
    Mol Ther; 2001 Jun; 3(6):940-6. PubMed ID: 11407908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful correction of the human Cooley's anemia beta-thalassemia major phenotype using a lentiviral vector flanked by the chicken hypersensitive site 4 chromatin insulator.
    Malik P; Arumugam PI; Yee JK; Puthenveetil G
    Ann N Y Acad Sci; 2005; 1054():238-49. PubMed ID: 16339671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic globin gene delivery using lentiviral vectors.
    Rivella S; Sadelain M
    Curr Opin Mol Ther; 2002 Oct; 4(5):505-14. PubMed ID: 12435053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy for hemoglobinopathies: are we there yet?
    Puthenveetil G; Malik P
    Curr Hematol Rep; 2004 Jul; 3(4):298-305. PubMed ID: 15217560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene therapy for the hemoglobin disorders.
    Persons DA; Nienhuis AW
    Curr Hematol Rep; 2003 Jul; 2(4):348-55. PubMed ID: 12901333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference.
    Samakoglu S; Lisowski L; Budak-Alpdogan T; Usachenko Y; Acuto S; Di Marzo R; Maggio A; Zhu P; Tisdale JF; Rivière I; Sadelain M
    Nat Biotechnol; 2006 Jan; 24(1):89-94. PubMed ID: 16378095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemoglobin gene therapy for β-thalassemia.
    Bank A
    Hematol Oncol Clin North Am; 2010 Dec; 24(6):1187-201. PubMed ID: 21075288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Globin gene transfer as a potential treatment for the beta-thalassaemias and sickle cell disease.
    Sadelain M
    Vox Sang; 2004 Jul; 87 Suppl 2():235-42. PubMed ID: 15209924
    [No Abstract]   [Full Text] [Related]  

  • 14. On the road to gene therapy for beta-thalassemia and sickle cell anemia.
    Bank A
    Pediatr Hematol Oncol; 2008; 25(1):1-4. PubMed ID: 18231949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy for homozygous beta-thalassemia. Is it a reality?
    Boulad F; Rivière I; Sadelain M
    Hemoglobin; 2009; 33 Suppl 1():S188-96. PubMed ID: 20001625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial correction of murine beta-thalassemia with a gammaretrovirus vector for human gamma-globin.
    Nishino T; Tubb J; Emery DW
    Blood Cells Mol Dis; 2006; 37(1):1-7. PubMed ID: 16814578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I/II clinical trial of beta-globin gene therapy for beta-thalassemia.
    Bank A; Dorazio R; Leboulch P
    Ann N Y Acad Sci; 2005; 1054():308-16. PubMed ID: 16339679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on gene therapy for hemoglobin disorders.
    Persons DA
    Curr Opin Mol Ther; 2003 Oct; 5(5):508-16. PubMed ID: 14601520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of sickle cell disease in transgenic mouse models by gene therapy.
    Pawliuk R; Westerman KA; Fabry ME; Payen E; Tighe R; Bouhassira EE; Acharya SA; Ellis J; London IM; Eaves CJ; Humphries RK; Beuzard Y; Nagel RL; Leboulch P
    Science; 2001 Dec; 294(5550):2368-71. PubMed ID: 11743206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of an anti-sickling beta-globin in human erythroblasts derived from retrovirally transduced primitive normal and sickle cell disease hematopoietic cells.
    Oh IH; Fabry ME; Humphries RK; Pawliuk R; Leboulch P; Hoffman R; Nagel RL; Eaves C
    Exp Hematol; 2004 May; 32(5):461-9. PubMed ID: 15145214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.